XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues      
Total revenues $ 820,222 $ 625,486 $ 391,005
Cost and expenses      
Research and development 316,415 264,208 100,035
Selling, general and administrative 588,591 511,034 303,627
Total cost and expenses 1,361,262 1,093,660 607,282
Loss from operations (541,040) (468,174) (216,277)
Interest expense (9,319) (8,305) (15,082)
Interest and other income, net 3,538 5,381 7,562
Loss on debt extinguishment     (5,848)
Loss before income taxes (546,821) (471,098) (229,645)
Income tax expense (978) (618) (98)
Net loss (547,799) (471,716) (229,743)
Unrealized loss on available-for-sale securities, net of tax (14,075) (6,546) 3,340
Comprehensive loss $ (561,874) $ (478,262) $ (226,403)
Net loss per share (Note 13):      
Basic (in dollars per share) $ (5.57) $ (5.21) $ (2.84)
Diluted (in dollars per share) $ (5.57) $ (5.21) $ (2.84)
Weighted-average number of shares used in computing basic and diluted net loss per share:      
Basic (in shares) 98,408 90,558 81,011
Diluted (in shares) 98,408 90,558 81,011
Product      
Revenues      
Total revenues $ 797,307 $ 580,080 $ 377,877
Cost and expenses      
Cost of revenues 453,632 315,195 200,097
Licensing and other      
Revenues      
Total revenues 22,915 45,406 13,128
Cost and expenses      
Cost of revenues $ 2,624 $ 3,223 $ 3,523